← Evidence library

BIB_355

NICE Draft Guidance December 2025 — DRAFT NOT recommend lifileucel for previously treated unresectable/metastatic melanoma.

Evidence grade

A

Tier

1 (Melanoma Focus official + NICE project pa

Cited by tasks

17, 18, 19a

Identifiers

PMC12914490 · DOI:10.1001/jamanetworkopen · PMID:41701495

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_355/findings.md (research corpus). This page is a short context summary — not individualised medical advice.